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Chromosome 22q11.2 deletion syndrome is a clinically heterogeneous condition of 
intellectual disability, parathyroid and thyroid hypoplasia, palatal abnormalities, 
cardiac malformations and psychiatric symptoms. Hyperphagia and childhood obesity 
is widely reported in Prader-Willi Syndrome (PWS) but there is only one previous 
report of this presentation in chromosome 22q11.2 deletion syndrome. We describe 
two further cases of chromosome 22q11.2 deletion syndrome in which hyperphagia 
and childhood obesity were the presenting features. This may be a manifestation of 
obsessive behaviour secondary to some of the psychiatric features commonly seen in 
chromosome 22q11.2 deletion syndrome. Serious complications may result from 
hyperphagia and childhood obesity therefore early recognition and intervention is 
crucial. Due to the similar clinical presentation of these two patients to patients with 
PWS, it is suggested that the hyperphagia seen here should be managed in a similar 
way to how it is managed in PWS. 
 
Introduction  
Chromosome 22q11.2 deletion syndrome (22q11.2delS) is characterised by 
intellectual disability, parathyroid and thymic hypoplasia, palatal abnormalities, facial 
dysmorphisms, short stature and cardiac outflow tract malformations [1] [2]. A 
significant and common component of 22q11 deletion syndrome are its 
neuropsychiatric features, most notably autistic spectrum disorder (ASD), obsessive 
compulsive disorder (OCD), and schizophrenia in later life [3].  
 
Hyperphagia and obesity is a major feature of Prader Willi syndrome (PWS), 
manifesting as poor feeding in the first year of life due to a poor suckling reflex and 
hypotonia, followed by hyperphagia and obsessive and abnormal behaviour around 
food such as hoarding, gorging and eating non-food items from around age 2 [4]. The 
hyperphagia seen in PWS is a significant problem as it can lead to morbid obesity in 
adolescence and adulthood as well as stomach rupture, cardiovascular disease, sleep 
apnoea and thrombophlebitis if not treated early. 
 
Although there are some known cases of 22q11.2delS in patients with obesity [5] , 
only a single patient with 22q11.2 has been reported with childhood hyperphagia [6]. 
We report on two additional cases of children with confirmed 22q11.2delS who 
presented in our clinics with these features. 
 
Case 1  
An 11 year old boy presented with small and undeveloped genitalia, delayed puberty, 
learning difficulties, severe speech delay and obesity. 
 
He was the 4th child to healthy non-consanguineous parents. His siblings were healthy. 
There was no history of familial obesity. He was born at 37 weeks by spontaneous 
vaginal delivery with a birth weight of 3.17kg.  As a neonate he was lethargic and had 
poor feeding including vomiting. Initially his weight gain was poor, however by age 3 
years, he started to eat excessively and became obese, displaying food seeking and 













the 99.6th centile (69.5kg) and his height was on the 50th centile (145cm), for a BMI 
of 33. 
 
He had recurrent chest infections in early childhood. He manifested global 
developmental delay and attended mainstream school with support for moderate 
learning difficulties.  
 
He presented with behavioural problems including urinating and showing his genitals 
in public. He also displayed a lack of imaginative play and was uninterested in 
engaging with other children. At the age of 8 years he was diagnosed with severe 
OCD and anxiety in the context of ASD and was started on treatment with a selective 
serotonin reuptake inhibitor (SSRI). 
 
By 11 years and 4 months he showed no signs of puberty. His penis was impeded in 
pubic fat and measured 4cm. Both testes were present and had an equal volume of 
3cm. He lacked both pubic and axillary hair. 
 
The patient had dysmorphic features including almond-shaped eyes, hypertelorism, 
flat philtrum, epicanthic folds, short palpebral fissures, notched nasal tip and a flat 
nasal bridge. He had nasal speech that was difficult to understand. 
 
An echocardiogram and audiometry showed normal results. A renal ultrasound 
showed right renal agenesis. Urea and electrolytes were normal. He had a slightly 
raised creatinine as well as IgA levels and low IgM levels.  
 
 
Case 2  
A five year old girl presented due to concerns regarding eating behaviour including 
excessive over-eating and weight gain.  
 
She was the 4th child of healthy of non-consanguineous parents. All previous children 
were healthy; a maternal aunt had pulmonary stenosis. There was no history of 
familial obesity. During pregnancy she was found to have echogenic bowel and a 
single umbilical artery. Umbilical cord compression at delivery resulted in an 
emergency caesarean section at 38 weeks. Her birth weight was 3.25kg.  
 
She initially had no feeding problems, however following weaning to solids she 
developed a large appetite. At 13 months, following surgery for the correction of 
patent ductus arteriosus, she started gaining weight. By age 6 her weight was on the 
99th centile (37.4kg), height was on the 91st  (121.3cm) and head circumference 
between the 2nd and 9th  (50cm). Her parents experienced difficulties  in controling her 
constant, food-seeking behaviour. She developed significant truncal obesity with 
gynaecomastia.  
 
She suffered from recurrent chest infections in early childhood as well as an episode 
of orbital cellulitis. 
 
She manifested developmental delay: smiled by 9 weeks, sat unsupported by 9 
months, crawled by 13 months and walking by 19. There were no concerns about her 













She displayed imaginative play and there was no evidence of obsessions or rigid 
behaviours. She was both faecally and urinary incontinent and remained in nappies 
during the day. She attended mainstream school with one-to-one full time support for 
special educational needs. She was also found to have a short attention span and was 
easily distracted. 
 
She had over-folding of her upper helix but otherwise resembled both her parents. She 
had hyper-extensible finger, knee and ankle joints bilaterally with femoral anteversion. 
She was noted to have long curved fingers and flat, laterally deviated feet which were 
painful with deambulation.   
 
She had a normal audiology test. Her full blood count, immunoglobulins, 




On the basis of  their clinical presentation both patients had DNA methylation testing 
for chromosome 15q11-q13 which showed normal results. 
 
In patient 1 microarray analysis of peripheral blood using an OGT ISCA 8x60K oligo 
array interpreted with CytoSure Interpert v4.5 software with the genome build, 
GRCh37 at a resolution of 180kb found a recurrent 22q11 microdeletion 
(46,XY.arr[hg19] 22q11.21 (18,818,376 – 21,540,347) x 1), totalling approximately 
2.7Mb on microarray analysis. In patient two the same method was used, indentifying 
a recurrent 22q11 microdeletion (46,XY.arr[hg19] 22q11.21 (18,894,820 – 
21,025,719) x1) totalling approximately 2.1 Mb on microarray analysis. 
 
Following the positive microarray result, both parents had in situ hybridisation studies 
with a Kreatech TBX1 probe to 22q11.2 from a blood cell culture sample. The 




While obesity in 22q11.2delS has been reported [5], some studies have shown that the 
average BMI of  22q11.1 patients is no different to the general population [7].  
However in the two cases presented here, sudden weight gain and excessive eating 
with aggressive behaviour if food was withheld were prominent features of the 
presentation, to the extent that two independent clinical geneticists requested testing 
for PWS.  
 
Interestingly, the pattern of feeding problems was also similar to those seen in PWS in 
both patients, with both having poor feeding in the first year of life, followed by the 
onset of hyperphagia and obesity occurring in early childhood.  
 
Hyperphagia may be a manifestation of obsessive behaviour secondary to ASD 
sometimes observed in 22q11.2delS [8] [9] and is known to manifest in this way [10].  
 
This has implications for the management of individuals with 22q11.2delS. Treating 













disease, respiratory disease and type II diabetes. Dietary management overseen by a 
dietician from age 2-10 is an effective intervention [11].  
 
Treatment of behavioural and psychological aspects is also important in mitigating 
some of the compulsive behaviour related to ASD seen in 22q11.2delS and PWS. 
General measures to address this include utilising structure and routine to minimise 
anxiety related to ASD [12]. One therapy that has been shown to be effective against 
covert food stealing is applied behavioural analysis (ABA) [11]. Pharmacological and 
surgical treatment of hyperphagia in PWS is of limited effectiveness, however in 
cases of severe life threatening obesity bariatric surgery may be necessary [11]. 
 
As shown in PWS patients with hyperphagia early recognition and intervention can be 
effective in preventing the complications of severe obesity. Although these 
interventions have not been assessed specifically in 22q11.2delS, it is likely due to the 
similar presentation that these may prove beneficial. It is also important for clinicians 
to be aware of the possibility of hyperphagia in 22q11.2delS so diagnoses are not 
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